Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Alembic Limited (ALEMBICLTD.NS)
Vadodara, IN
Alembic Limited primarily manufactures and globally distributes active pharmaceutical ingredients (APIs) developed through both fermentation and chemical synthesis. The company operates across two distinct divisions: API and Real Estate. In its real estate ventures, Alembic undertakes the construction of residential and commercial properties, offers project management and marketing consultancy services, and leases commercial spaces. Furthermore, it operates its own power generation facilities, including co-generation plants with a total capacity of 11 MW and wind power plants contributing 5 MW. Founded in 1907 and headquartered in Vadodara, India, Alembic Limited is a subsidiary of Nirayu Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.10% | -2.40% | -4.29% | -5.37% | -10.60% | -13.53% | -21.86% | +30.40% | -34.75% | +199.66% | +2,076.62% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 |
|---|---|
| Strong Buy | 0 |
| Buy | 0 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
-
Revenue growth Real Estate - Development: +9.7%+8.2% Q1'26: -0.4% (vs Q1'25)
-
EPS growth Real Estate - Development: +20.5%+2.2% Q1'26: -2.2% (vs Q1'25)
-
FCF margin FCF growth · Real Estate - Development: +16.2%+38.8% Q1'26: +42.9% (vs Q1'25)
-
EBIT margin Real Estate - Development: +19.8%+32.5% ★ Q1'26: +28.1% (vs Q1'25)
-
ROIC Real Estate - Development: +3.2%+3.1% Q1'26: +2.5% (vs Q1'25)
-
Share dilution Real Estate - Development: +0.0%+0.0% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Real Estate - Development: 1.93×0.12× ★ Q1'26: 0.13× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2005 actual |
Mar 2006 actual |
Mar 2008 actual |
Mar 2009 actual |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.24B
est: 5.89B (-11.0%)
|
6.39B
est: 6.36B (+0.5%)
|
10.27B
est: 10.12B (+1.5%)
|
11.16B
est: 11.58B (-3.6%)
|
10.22B
est: 11.75B (-13.0%)
|
2.01B
est: 13.49B (-85.1%)
|
1.21B
est: 14.37B (-91.6%)
|
1.79B
est: 15.54B (-88.5%)
|
83.52B
83.52B – 83.52B
+437.6% YoY
|
94.54B
94.54B – 94.54B
+13.2% YoY
|
| EBITDA |
900.54M
est: 4.22B (-78.6%)
|
1.48B
est: 4.46B (-66.8%)
|
1.80B
est: 7.10B (-74.6%)
|
2.09B
est: 8.12B (-74.3%)
|
923.27M
est: 75.16M (+1,128.5%)
|
12.74M
est: 653.56M (-98.1%)
|
-9.59M
est: -36.00M (+73.4%)
|
260.22M
est: 11.17B (-97.7%)
|
60.80B
60.80B – 60.80B
+444.2% YoY
|
68.82B
68.82B – 68.82B
+13.2% YoY
|
| EBIT |
644.85M
est: 3.97B (-83.7%)
|
1.19B
est: 4.19B (-71.6%)
|
1.47B
est: 6.68B (-77.9%)
|
1.70B
est: 7.64B (-77.7%)
|
493.08M
est: 446.27M (+10.5%)
|
-87.94M
est: 799.16M (-111.0%)
|
-118.91M
est: -134.07M (+11.3%)
|
161.53M
est: 10.51B (-98.5%)
|
57.36B
57.36B – 57.36B
+445.8% YoY
|
64.92B
64.92B – 64.92B
+13.2% YoY
|
| Net Income |
518.16M
est: 630.51M (-17.8%)
|
785.22M
est: 630.68M (+24.5%)
|
1.12B
est: 846.99M (+32.5%)
|
108.17M
est: 599.41M (-82.0%)
|
395.38M
est: 109.54M (+261.0%)
|
-129.02M
est: 453.54M (-128.4%)
|
-121.98M
est: -139.48M (+12.5%)
|
114.93M
est: 2.27B (-94.9%)
|
9.86B
9.86B – 9.86B
+333.7% YoY
|
12.79B
12.79B – 12.79B
+29.7% YoY
|
| SGA |
948.05M
est: 394.10M (+140.6%)
|
1.09B
est: 416.61M (+161.8%)
|
1.51B
est: 663.28M (+127.4%)
|
1.77B
est: 759.29M (+133.6%)
|
921.61M
est: 2.22B (-58.5%)
|
18.97M
est: 2.73B (-99.3%)
|
2.23B
est: 312.47M (+614.3%)
|
39.17M
est: 1.04B (-96.2%)
|
6.94B
6.94B – 6.94B
+564.8% YoY
|
7.86B
7.86B – 7.86B
+13.2% YoY
|
| EPS |
1.94
est: 2.46 (-21.0%)
|
2.84
est: 2.47 (+15.1%)
|
4.05
est: 3.32 (+22.2%)
|
0.39
est: 2.35 (-83.4%)
|
0.77
est: 1.61 (-52.1%)
|
-0.34
est: 3.83 (-108.9%)
|
-0.36
est: 5.75 (-106.3%)
|
0.43
est: 8.81 (-95.1%)
|
38.40
38.40 – 38.40
+335.8% YoY
|
49.80
49.80 – 49.80
+29.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Udit C. Amin | MD & Director | 200.0K | male |
| Ambarish Jambhorkar | Associate Vice President of HR | — | male |
| Avaneesh Nath Sharma | President of Real Estate Operations | — | male |
| Kevalkumar Bharatkumar Thakkar | Company Secretary & Compliance Officer | — | male |
| Rasesh Shah | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALEMBICLTD.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
